Skip to main content
Clinical Trials/JPRN-jRCT1040210050
JPRN-jRCT1040210050
Recruiting
未知

Construction and validation of imaging diagnostic systems based on AI for rectal cancer

Ouchi Akira0 sites200 target enrollmentAugust 6, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
rectal cancer
Sponsor
Ouchi Akira
Enrollment
200
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 6, 2021
End Date
TBD
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Ouchi Akira

Eligibility Criteria

Inclusion Criteria

  • 1\) Pathologically diagnosed as adenocarcinoma (including mucinous, signet\-cell, and medullary carcinoma) based on the Japanese Classification of Colorectal, Appendiceal, and Anal Carcinoma (JCCAAC), 3rd English Edition on the resected specimen for rectal cancer
  • 2\) Performed abdominal and pelvic contrast\-enhanced CT (aortic bifurcation to pelvis) or abdominal and pelvic contrast\-enhanced MRI (aortic bifurcation to pelvis) before surgery.
  • 3\) Inversion depth was suspected cT2 or deeper on JCCAAC 3rd English Edition, mainly located at the low rectum or anal canal.
  • 4\) No preoperative chemotherapy or radiotherapy, and performed bilateral lateral pelvic lymph node dissection and primary rectal cancer resection.
  • 5\) No treatment history of surgery, chemotherapy, or radiotherapy for pelvic malignancies (including rectal, gynecologic, and urologic cancers).
  • 6\) No distant organ metastasis, distant lymph node metastasis, or peritoneal dissemination (not cStage IV) on preoperative images.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials